Journal article · 2026 · Open access
Deciphering the Structure−Activity Relationships Underpinning the Linkerology of Bivalent EGFR Inhibitors
Journal of Medicinal Chemistry, 69(20), 24838–24861 · Published 9 October 2026 · DOI 10.1021/acs.jmedchem.6c02714
In brief
“Deciphering the Structure−Activity Relationships Underpinning the Linkerology of Bivalent EGFR Inhibitors” is a 2026 journal article by Kishan B. Patel and 16 co-authors, published in Journal of Medicinal Chemistry. OpenAlex counts 1 citations as of 16 November 2026, which puts it in the top 9% of works published in 2026 by citations. It is open access under a CC BY licence: the full text is free to read at Journal of Medicinal Chemistry.
- Citations
- 1
- Most cited in
- 2026 (1)
- Field-weighted impact
- 1.58
- References
- 54
- Authors
- 17
Abstract
Linking small molecules that bind adjacent sites on a target is a promising strategy for developing compounds with tight binding affinities. ATP-allosteric bivalent inhibitors (AABIs) of the epidermal growth factor receptor (EGFR) have provided new insights into efficient linker design where large potency gains can be achieved through particular design scenarios. In this work, we systematically evaluated the structure-activity relationships of target molecules to better understand the most effective approach to maximizing potency through linker optimization. Our results show that linker length and points of connection are both important strategies for significant potency enhancements. Structures and simulations indicate that maximal flexibility is likely the most important design criterion for linking molecules that occupy adjacent pockets, as modeled by the EGFR kinase domain. These studies provide a general framework for the rational design of linkers broadly relevant to fragment-based drug discovery and a number of related scenarios in medicinal chemistry.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Patel, K. B., Akinwumi, I. A., Weber, T. M., MacDonald, M. R., Collins, S. J., Chitnis, S. P., Zack, C. L., Ogboo, B. C., Nasief, N. N., Ouellette, E. A., Abidakun, O. A., Eck, M. J., Brandt, A. L., Wittlinger, F., Laufer, S., Nguyen, H. T., & Heppner, D. E. (2026). Deciphering the Structure−Activity Relationships Underpinning the Linkerology of Bivalent EGFR Inhibitors. Journal of Medicinal Chemistry, 69(20), 24838–24861. https://doi.org/10.1021/acs.jmedchem.6c02714
MLA 9
Patel, Kishan B., et al. “Deciphering the Structure−Activity Relationships Underpinning the Linkerology of Bivalent EGFR Inhibitors.” Journal of Medicinal Chemistry, vol. 69, no. 20, 2026, pp. 24838–24861. https://doi.org/10.1021/acs.jmedchem.6c02714.
Chicago
Patel, Kishan B., Ishola Abeeb Akinwumi, Tess M. Weber, Monica R. MacDonald, Stephen J. Collins, Surbhi P. Chitnis, Colton L. Zack, et al. 2026. “Deciphering the Structure−Activity Relationships Underpinning the Linkerology of Bivalent EGFR Inhibitors.” Journal of Medicinal Chemistry 69 (20): 24838–24861. https://doi.org/10.1021/acs.jmedchem.6c02714.
Harvard
Patel, K. B. et al. (2026) ‘Deciphering the Structure−Activity Relationships Underpinning the Linkerology of Bivalent EGFR Inhibitors’, Journal of Medicinal Chemistry, 69(20), pp. 24838–24861. doi:10.1021/acs.jmedchem.6c02714.
IEEE
K. B. Patel et al., “Deciphering the Structure−Activity Relationships Underpinning the Linkerology of Bivalent EGFR Inhibitors,” Journal of Medicinal Chemistry, vol. 69, no. 20, pp. 24838–24861, 2026, doi: 10.1021/acs.jmedchem.6c02714.
BibTeX
@article{patel2026deciphering,
title = {{Deciphering the Structure−Activity Relationships Underpinning the Linkerology of Bivalent EGFR Inhibitors}},
author = {Patel, Kishan B. and Akinwumi, Ishola Abeeb and Weber, Tess M. and MacDonald, Monica R. and Collins, Stephen J. and Chitnis, Surbhi P. and Zack, Colton L. and Ogboo, Blessing C. and Nasief, Nader N. and Ouellette, Emily A. and Abidakun, Omobolanle A. and Eck, Michael J. and Brandt, Asher L. and Wittlinger, Florian and Laufer, Stefan and Nguyen, Hung Tan and Heppner, David E.},
journal = {Journal of Medicinal Chemistry},
year = {2026},
volume = {69},
number = {20},
pages = {24838--24861},
doi = {10.1021/acs.jmedchem.6c02714},
url = {https://doi.org/10.1021/acs.jmedchem.6c02714}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- bivalent inhibitors
- EGFR
- structure-activity relationship
- linker design
- linker length
- fragment-based drug discovery
- kinase domain
- molecular flexibility
Work with this paper
Most-cited papers in Pharmacology, Toxicology and Pharmaceutics
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingOleg Trott, Arthur J. Olson · Journal of Computational Chemistry · 2009 · 39,860 citations
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityGarrett M. Morris, Ruth Huey, William Lindstrom and 4 more · Journal of Computational Chemistry · 2009 · 26,508 citations
- Development and testing of a general amber force fieldJunmei Wang, Romain M. Wolf, James W. Caldwell and 2 more · Journal of Computational Chemistry · 2004 · 20,080 citations
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1Christopher A. Lipinski, Franco Lombardo, Beryl W. Dominy and 1 more · Advanced Drug Delivery Reviews · 2001 · 19,638 citations
- SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small moleculesAntoine Daina, Olivier Alain Michielin, Vincent Zoete · Scientific Reports · 2017 · 19,557 citations
All highly cited Pharmacology, Toxicology and Pharmaceutics papers
Questions about this paper
How do I cite this paper in APA style?
Patel, K. B., Akinwumi, I. A., Weber, T. M., MacDonald, M. R., Collins, S. J., Chitnis, S. P., Zack, C. L., Ogboo, B. C., Nasief, N. N., Ouellette, E. A., Abidakun, O. A., Eck, M. J., Brandt, A. L., Wittlinger, F., Laufer, S., Nguyen, H. T., & Heppner, D. E. (2026). Deciphering the Structure−Activity Relationships Underpinning the Linkerology of Bivalent EGFR Inhibitors. Journal of Medicinal Chemistry, 69(20), 24838–24861. https://doi.org/10.1021/acs.jmedchem.6c02714
How many times has this paper been cited?
1 times, according to OpenAlex on 16 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Journal of Medicinal Chemistry: sign in and open the full text from this page.
Who wrote this paper?
Kishan B. Patel, Ishola Abeeb Akinwumi, Tess M. Weber, Monica R. MacDonald, Stephen J. Collins, Surbhi P. Chitnis, Colton L. Zack, Blessing C. Ogboo, Nader N. Nasief, Emily A. Ouellette, Omobolanle A. Abidakun, Michael J. Eck and 5 more.
What is the DOI of this paper?
10.1021/acs.jmedchem.6c02714, permanently at https://doi.org/10.1021/acs.jmedchem.6c02714. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 16 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.